MCID: RMS001
MIFTS: 41

Rem Sleep Behavior Disorder malady

Categories: Mental diseases

Aliases & Classifications for Rem Sleep Behavior Disorder

Aliases & Descriptions for Rem Sleep Behavior Disorder:

Name: Rem Sleep Behavior Disorder 12 52 42 14 69
Rapid Eye Movement Sleep Behavior Disorder 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9091
ICD10 33 G47.52
ICD9CM 35 327.42
MeSH 42 D020187
SNOMED-CT 64 415238003
UMLS 69 C0751772

Summaries for Rem Sleep Behavior Disorder

Disease Ontology : 12 A sleep disorder that involves abnormal behavior including the acting out of violent or dramatic dreams during the sleep phase with rapid eye movement.

MalaCards based summary : Rem Sleep Behavior Disorder, also known as rapid eye movement sleep behavior disorder, is related to machado-joseph disease and dementia. An important gene associated with Rem Sleep Behavior Disorder is SNCA (Synuclein Alpha), and among its related pathways/superpathways are Neuroscience and Monoamine Transport. The drugs Dopamine and Hydrocortisone have been mentioned in the context of this disorder. Affiliated tissues include eye, brain and testes, and related phenotypes are behavior/neurological and nervous system

Wikipedia : 71 Rapid eye movement sleep behavior disorder (RBD) is a sleep disorder (more specifically a parasomnia)... more...

Related Diseases for Rem Sleep Behavior Disorder

Diseases related to Rem Sleep Behavior Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 64)
id Related Disease Score Top Affiliating Genes
1 machado-joseph disease 11.5
2 dementia 10.5
3 narcolepsy 10.4
4 sleep apnea 10.3
5 obstructive sleep apnea 10.2
6 synucleinopathy 10.2
7 ceroid lipofuscinosis, neuronal, 1 10.2 LRRK2 SNCA
8 lethal congenital contracture syndrome 8 10.2 LRRK2 SNCA
9 spink1-related hereditary pancreatitis 10.2 LRRK2 SNCA
10 transient neonatal myasthenia gravis 10.2 LRRK2 SNCA
11 thrombosis 10.2 LRRK2 SNCA
12 multiple system atrophy 10.2
13 trichothiodystrophy 3, photosensitive 10.2 LRRK2 SNCA
14 riedel's fibrosing thyroiditis 10.2 LRRK2 SNCA
15 klippel-feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism 10.2 LRRK2 SNCA
16 deafness, autosomal recessive 101 10.1 RPS27A SNCA
17 cystic echinococcosis 10.1 RPS27A SNCA
18 cyprus facial neuromusculoskeletal syndrome 10.1 RPS27A SNCA
19 pythiosis 10.1 ACHE SNCA
20 hemangioblastoma 10.1 HCRT SNCA
21 nephrogenic adenoma of the urethra 10.1 SLC6A3 SNCA
22 sleep disorder 10.1
23 plekhm1-related autosomal recessive osteopetrosis 10.1 LRRK2 SNCA
24 benign partial epilepsy with secondarily generalized seizures in infancy 10.1 LRRK2 SLC6A3 SNCA
25 atrial septal defect 9 10.1 HCRT SNCA
26 thyrotropin-releasing hormone deficiency 10.1 LRRK2 SLC6A3 SNCA
27 cavernous hemangioma 10.1 LRRK2 SLC6A3 SNCA
28 ovarian mucinous adenocarcinoma 10.0 ACHE SLC6A3 SNCA
29 mitochondrial dna depletion syndrome 3 10.0 SLC6A3 SNCA
30 hypoproteinemia, hypercatabolic 10.0 LRRK2 RPS27A SNCA
31 proteus syndrome, somatic 10.0 RPS27A SLC6A3 SNCA
32 squamous blepharitis 10.0 SNCA TCOF1
33 myopathy, distal, with early respiratory failure, autosomal dominant 10.0 HCRT SLC6A3
34 rheumatoid arthritis 10.0
35 arthritis 10.0
36 corticobasal degeneration 10.0
37 pure autonomic failure 10.0
38 autoimmune disease of urogenital tract 10.0 LRRK2 SNCA
39 personality disorder 10.0 HCRT SLC6A3 SNCA
40 usher syndrome 10.0 HCRT SLC6A3
41 preeclampsia/eclampsia 5 9.9 SLC17A5 SLC6A3 SNCA
42 eumycotic mycetoma 9.9 ACHE LRRK2 SLC6A3 SNCA
43 substance-induced psychosis 9.9 ACHE LRRK2 SLC6A3 SNCA
44 autism 19 9.9 LRRK2 RPS27A SLC6A3 SNCA
45 gallbladder adenoma 9.9 LRRK2 RPS27A SLC6A3 SNCA
46 hemochromatosis, type 2a 9.9 LRRK2 RPS27A SLC6A3 SNCA
47 cardiomyopathy, dilated, 1u 9.9 ACHE LRRK2 RPS27A SNCA
48 alzheimer disease 9.8
49 obsessive-compulsive disorder 9.8
50 restless legs syndrome 9.8

Graphical network of the top 20 diseases related to Rem Sleep Behavior Disorder:



Diseases related to Rem Sleep Behavior Disorder

Symptoms & Phenotypes for Rem Sleep Behavior Disorder

MGI Mouse Phenotypes related to Rem Sleep Behavior Disorder:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.43 ACHE HCRT LRRK2 SLC17A5 SLC6A3 SNCA
2 nervous system MP:0003631 9.17 ACHE HCRT LRRK2 SLC17A5 SLC6A3 SNCA

Drugs & Therapeutics for Rem Sleep Behavior Disorder

Drugs for Rem Sleep Behavior Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 81)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
2
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754 657311
3
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
4
Citalopram Approved Phase 4 59729-33-8 2771
5
Olanzapine Approved, Investigational Phase 4 132539-06-1 4585
6
Ziprasidone Approved Phase 4 146939-27-7 60854
7
Histamine Approved, Investigational Phase 4 75614-87-8, 51-45-6 774
8
Mianserin Approved Phase 4 24219-97-4 4184
9
Melatonin Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3 73-31-4 896
10
Serotonin Phase 4 50-67-9 5202
11 Muscarinic Antagonists Phase 4
12 Cholinergic Agents Phase 4,Phase 3,Phase 1,Phase 2
13 Cholinergic Antagonists Phase 4
14 Serotonin Agents Phase 4
15 Serotonin Uptake Inhibitors Phase 4
16 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
17 Cortisol succinate Phase 4
18 Neurotransmitter Uptake Inhibitors Phase 4
19 Cytochrome P-450 CYP2D6 Inhibitors Phase 4
20 Cytochrome P-450 Enzyme Inhibitors Phase 4
21 Hormones Phase 4
22 Parasympatholytics Phase 4
23 Peripheral Nervous System Agents Phase 4,Phase 2
24 Dopamine Agents Phase 4
25 Dopamine Uptake Inhibitors Phase 4
26 Hydrocortisone 17-butyrate 21-propionate Phase 4
27 Hydrocortisone acetate Phase 4
28 Antidepressive Agents Phase 4,Phase 2
29 Antidepressive Agents, Second-Generation Phase 4
30 Psychotropic Drugs Phase 4,Phase 2
31 Autonomic Agents Phase 4,Phase 2
32 Antiparkinson Agents Phase 4
33 Dopamine agonists Phase 4
34 Adrenergic Agents Phase 4,Phase 2
35 Serotonin Antagonists Phase 4
36 Adrenergic Antagonists Phase 4,Phase 2
37 Gastrointestinal Agents Phase 4
38 Adrenergic alpha-Antagonists Phase 4,Phase 2
39 Tranquilizing Agents Phase 4
40 Dopamine Antagonists Phase 4
41 Protective Agents Phase 4,Phase 3,Phase 2
42 Antiemetics Phase 4
43 Antipsychotic Agents Phase 4,Phase 2
44 Antioxidants Phase 4,Phase 2,Phase 3
45 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Early Phase 1
46
Histamine Phosphate Phase 4 51-74-1 65513
47 Histamine Antagonists Phase 4
48 Histamine H1 Antagonists Phase 4
49 Pharmaceutical Solutions Phase 4,Phase 2
50
Iodine Phase 4 7553-56-2 807

Interventional clinical trials:

(show top 50) (show all 67)
id Name Status NCT ID Phase
1 Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder Unknown status NCT00442481 Phase 4
2 Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With Depression Unknown status NCT00106197 Phase 4
3 Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior Disorder Completed NCT01401413 Phase 4
4 Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease Completed NCT02162862 Phase 4
5 An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression Completed NCT00835107 Phase 4
6 An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients Completed NCT00520507 Phase 4
7 Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study Recruiting NCT02836743 Phase 4
8 Treatment of Sleep Disturbances in Trauma-affected Refugees Recruiting NCT02761161 Phase 4
9 DaTSCAN Imaging in Aging and Neurodegenerative Disease Enrolling by invitation NCT01453127 Phase 4
10 Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease Enrolling by invitation NCT02768077 Phase 4
11 Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia Completed NCT00767091 Phase 3
12 Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia Completed NCT00856973 Phase 3
13 Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia Completed NCT00857220 Phase 3
14 Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia Not yet recruiting NCT02798367 Phase 2, Phase 3
15 Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism Completed NCT02312908 Phase 2
16 The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism Completed NCT00695136 Phase 1, Phase 2
17 Rapid Antidepressant Effects of Yohimbine in Major Depression Completed NCT00078715 Phase 2
18 Pilot Study of Melatonin and Epilepsy Completed NCT00965575 Phase 2
19 Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD) Recruiting NCT02708186 Phase 2
20 A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease Recruiting NCT02818777 Phase 2
21 Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder Enrolling by invitation NCT02871427 Phase 2
22 Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease Not yet recruiting NCT02789592 Phase 2
23 A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism Terminated NCT01887132 Phase 2
24 A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary Insomnia Withdrawn NCT00748592 Phase 2
25 A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes Completed NCT01780272 Phase 1
26 Understanding the Natural History of REM Sleep Behavior Disorder Unknown status NCT01674998
27 Acupuncture for the Sleep Disorder of Chronic Fatigue Syndrome Unknown status NCT01534130
28 Sleep Promotion in Critically Ill and Injured Patients Cared for in the Intensive Care Unit Unknown status NCT01082016
29 Brain Imaging in the Idiopathic REM Sleep Behavior Disorder (ALICE) Completed NCT03072940
30 MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder. Completed NCT01547481
31 Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease Completed NCT00492115
32 Effects of Napping in Sleep-Restricted Adolescents Completed NCT02838095
33 Dopamine Transporter Density Profiles in Patients With Periodic Limb Movements Completed NCT01365364
34 Cognitive Behavioral Therapy for the Treatment of Depression-Related Insomnia Completed NCT00255905
35 Sleep Investigation in Respirator Treated ICU Patients: the Importance of Intensive Environment Completed NCT01681043
36 Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps Completed NCT02325128
37 Combined and Isolated Effects of Sleep Deprivation and Alcohol Intake on Exercise Performance in Humans. Completed NCT02117193
38 SLEEP AND OSA ON REPRODUCTIVE FUNCTION IN MEN Completed NCT01884454
39 The Effect of the Mediterranean Diet on Obstructive Sleep Apnoea-Hypopnoea Syndrome: A Randomised Trial Completed NCT01312558
40 Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder Recruiting NCT02824341
41 Detecting Parkinson's Disease Through Speech Analysis Recruiting NCT03133611
42 Gait and REM Sleep Behavior Disorder Recruiting NCT02554331
43 Prospective Neuroimaging Investigation of Idiopathic REM Sleep Behavior Disorder Recruiting NCT02984137
44 Exploration of the Mechanism of Movement Improvement During RBD in Parkinson's Disease Using NIRS Recruiting NCT03060239
45 RBD Longitudinal as Prognostic for PD Recruiting NCT00817726
46 Natural History Study of Synucleinopathies Recruiting NCT01799915
47 Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease Recruiting NCT02640339
48 Cohort Study to Identify Predictor Factors of Onset and Progression of Parkinson's Disease Recruiting NCT02305147
49 Exploring the Relationship Between Alpha-synucleinopathy Related Non-motor Symptom and Post-op. Delirium in Elderly Patients With Spine Surgery Recruiting NCT02550626
50 Sleep, Awake & Move - Part II Recruiting NCT02710487

Search NIH Clinical Center for Rem Sleep Behavior Disorder

Cochrane evidence based reviews: rem sleep behavior disorder

Genetic Tests for Rem Sleep Behavior Disorder

Anatomical Context for Rem Sleep Behavior Disorder

MalaCards organs/tissues related to Rem Sleep Behavior Disorder:

39
Eye, Brain, Testes, Heart, Pons

Publications for Rem Sleep Behavior Disorder

Articles related to Rem Sleep Behavior Disorder:

(show top 50) (show all 362)
id Title Authors Year
1
Alterations of awake EEG in idiopathic REM sleep behavior disorder without cognitive impairment. ( 27894921 )
2017
2
Transcranial sonography in idiopathic REM sleep behavior disorder and multiple system atrophy. ( 27898200 )
2016
3
Caring burden of REM sleep behavior disorder - spouses' health and marital relationship. ( 27810184 )
2016
4
The Evolution of REM Sleep Behavior Disorder in Early Parkinson Disease. ( 27306265 )
2016
5
Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies. ( 27060952 )
2016
6
Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. ( 27010070 )
2016
7
Screening for REM sleep behavior disorder in the general population. ( 27697450 )
2016
8
Depressed REM Sleep Behavior Disorder Patients Are Less Likely to Recall Enacted Dreams than Non-Depressed Ones. ( 27081385 )
2016
9
Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk? ( 28082168 )
2016
10
Seeking Good Alternatives to Clonazepam: Suggestions for Future Treatment Trials in REM Sleep Behavior Disorder. ( 27448419 )
2016
11
National validation and proposed revision of REM sleep behavior disorder screening questionnaire (RBDSQ). ( 27671482 )
2016
12
Brain pathway differences between Parkinson's disease patients with and without REM sleep behavior disorder. ( 27853964 )
2016
13
Many faces of REM sleep behavior disorder: an editorial. ( 26750738 )
2016
14
Detecting the cognitive prodrome of dementia with Lewy bodies: A prospective study of REM sleep behavior disorder. ( 27692054 )
2016
15
Reduced intraepidermal nerve fiber density in patients with REM sleep behavior disorder. ( 27318706 )
2016
16
Loss of REM sleep features across nighttime in REM sleep behavior disorder. ( 26847988 )
2016
17
Abnormal baseline brain activity in Parkinson's disease with and without REM sleep behavior disorder: A resting-state functional MRI study. ( 27880010 )
2016
18
Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease. ( 27070245 )
2016
19
Brain imaging findings in idiopathic REM sleep behavior disorder (RBD) - A systematic review on potential biomarkers for neurodegeneration. ( 27542516 )
2016
20
Periodic Limb Movements during Sleep Mimicking REM Sleep Behavior Disorder. ( 27923426 )
2016
21
The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder. ( 27131830 )
2016
22
Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder. ( 26656284 )
2016
23
Effects of Rotigotine on REM Sleep Behavior Disorder in Parkinson Disease. ( 27568909 )
2016
24
Comparison between Automatic and Visual Scorings of REM Sleep without Atonia for the Diagnosis of REM Sleep Behavior Disorder in Parkinson Disease. ( 27923423 )
2016
25
A case series of REM sleep behavior disorder in pure autonomic failure. ( 27757562 )
2016
26
Risk Factor Profile in Parkinson's Disease Subtype with REM Sleep Behavior Disorder. ( 26889635 )
2016
27
REM sleep behavior disorder and periodic leg movements during sleep in ALS. ( 27027974 )
2016
28
Metabolic abnormality of pontine tegmentum in patients with REM sleep behavior disorder analyzed using magnetic resonance spectroscopy. ( 27448046 )
2016
29
Absence of LRRK2 mutations in a cohort of patients with idiopathic REM sleep behavior disorder. ( 26747879 )
2016
30
REM sleep behavior disorder was associated with Parkinson's disease: a community-based study. ( 27484952 )
2016
31
Pareidolias in REM sleep behavior disorder: a possible predictive marker of Lewy body diseases? ( 27855735 )
2016
32
Treatment of REM Sleep Behavior Disorder. ( 27752878 )
2016
33
The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease. ( 27538667 )
2016
34
Electrophysiological Evidence for Alternative Motor Networks in REM Sleep Behavior Disorder. ( 27852786 )
2016
35
Cognitive study on Chinese patients with idiopathic REM sleep behavior disorder. ( 27288781 )
2016
36
Prediction of later clinical course by a specific glucose metabolic pattern in non-demented patients with probable REM sleep behavior disorder admitted to a memory clinic: A case study. ( 26754469 )
2016
37
Risk factors for probable REM sleep behavior disorder: A community-based study. ( 26819459 )
2016
38
Efficacy of sodium oxybate on REM sleep behavior disorder in a patient with narcolepsy type 1. ( 27807183 )
2016
39
Central Apneas and REM Sleep Behavior Disorder as an Initial Presentation of Multiple System Atrophy. ( 26518702 )
2015
40
The Role of the Serotonergic System in REM Sleep Behavior Disorder. ( 25845692 )
2015
41
Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. ( 25454845 )
2015
42
Idiopathic REM Sleep Behavior Disorder: A Report on Two Cases with Contrasting Features. ( 26664088 )
2015
43
Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression. ( 25568298 )
2015
44
Parkinson disease with REM sleep behavior disorder: features, I+-synuclein, and inflammation. ( 25663225 )
2015
45
Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder? ( 26410306 )
2015
46
Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease. ( 27060938 )
2015
47
REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. ( 26366513 )
2015
48
Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression. ( 25929659 )
2015
49
Sleepiness in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease. ( 26085299 )
2015
50
Differential diagnosis of sporadic adult-onset ataxia: The role of REM sleep behavior disorder. ( 25899546 )
2015

Variations for Rem Sleep Behavior Disorder

Expression for Rem Sleep Behavior Disorder

Search GEO for disease gene expression data for Rem Sleep Behavior Disorder.

Pathways for Rem Sleep Behavior Disorder

GO Terms for Rem Sleep Behavior Disorder

Cellular components related to Rem Sleep Behavior Disorder according to GeneCards Suite gene sharing:

(show all 11)
id Name GO ID Score Top Affiliating Genes
1 neuronal cell body GO:0043025 9.63 LRRK2 SLC6A3 SNCA
2 lysosome GO:0005764 9.61 LRRK2 SLC17A5 SNCA
3 cell junction GO:0030054 9.55 ACHE HCRT LRRK2 SLC17A5 SNCA
4 axon GO:0030424 9.54 LRRK2 SLC6A3 SNCA
5 synaptic vesicle membrane GO:0030672 9.49 LRRK2 SLC17A5
6 terminal bouton GO:0043195 9.48 LRRK2 SNCA
7 synaptic vesicle GO:0008021 9.43 HCRT LRRK2 SNCA
8 rough endoplasmic reticulum GO:0005791 9.4 HCRT SNCA
9 inclusion body GO:0016234 9.32 LRRK2 SNCA
10 postsynapse GO:0098794 9.13 HCRT LRRK2 SNCA
11 synapse GO:0045202 9.02 ACHE HCRT LRRK2 SLC17A5 SNCA

Biological processes related to Rem Sleep Behavior Disorder according to GeneCards Suite gene sharing:

(show all 11)
id Name GO ID Score Top Affiliating Genes
1 negative regulation of protein phosphorylation GO:0001933 9.49 LRRK2 SNCA
2 negative regulation of neuron death GO:1901215 9.48 LRRK2 SNCA
3 response to cocaine GO:0042220 9.46 SLC6A3 SNCA
4 receptor internalization GO:0031623 9.43 ACHE SNCA
5 regulation of neuron death GO:1901214 9.4 LRRK2 SNCA
6 regulation of neurotransmitter secretion GO:0046928 9.37 HCRT SNCA
7 neurotransmitter biosynthetic process GO:0042136 9.32 ACHE SLC6A3
8 dopamine biosynthetic process GO:0042416 9.26 SLC6A3 SNCA
9 regulation of locomotion GO:0040012 9.16 LRRK2 SNCA
10 dopamine uptake involved in synaptic transmission GO:0051583 8.96 SLC6A3 SNCA
11 excitatory postsynaptic potential GO:0060079 8.8 HCRT LRRK2 SNCA

Sources for Rem Sleep Behavior Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....